Cite
APA Citation
Planchard, D., Besse, B., Groen, H. J. M., Souquet, P., Quoix, E., Baik, C. S., Barlesi, F., Kim, T. M., Mazieres, J., Novello, S., Rigas, J. R., Upalawanna, A., D'Amelio, A. M., Zhang, P., Mookerjee, B., & Johnson, B. E. (n.d.). dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial. Lancet oncology, 17(7), 984–993. http://access.bl.uk/ark:/81055/vdc_100033361369.0x00003d